Stapgen
About this raise
Stapgen, with a valuation of $20 million, is raising funds on Wefunder. The company has developed its patented STAP-Test, used as the preventive test for Type 2 diabetes. The test will be used to detect the risk of Type 2 diabetes in advance, even before the rise of blood sugar, so that the disease can be intercepted. Stapgen is led by an experienced team and has granted a patent for the US with patents pending in other countries. Biplab K. Malo founded Stapgen in February 2022. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $85,000. The campaign proceeds will be used for product development, lab rental, and product promotion.
Investment Overview
Not Funded: $0
Deal Terms
Total Commitments
- Platform
- Wefunder
- Start Date
- 11/15/2022
- Close Date
- 12/17/2022
$50,000
$85,000
$100
SAFE
Early Stage
RegCF
$20,000,000
0%
Company & Team
Company
- Year Founded
- 2022
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $15,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 12/17/2022 | Wefunder | $20,000,000 | $0 | SAFE | Not Funded | RegCF |